HAVLF.US HAVN Life Sciences Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 15, 2026
Market cap
USD 1.47K
P/E
-
P/B
0.53x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2023.

Is HAVLF.US undervalued?

Graham number

The Graham number of HAVN Life Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

HAVN Life Sciences Inc fundamental analysis

No fundamental analysis for HAVN Life Sciences Inc yet.

HAVN Life Sciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About HAVN Life Sciences Inc

HAVN Life Sciences Inc., a biotechnology company, engages in research and development of products for addressing mental health disorders. The company is developing formulations to support clinical trials addressing PTSD recovery and other trauma related disorders. It also focuses on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatment to support brain health and enhance the capabilities of the …

Full company profile